{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:58:34Z","timestamp":1793501914719,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00284-021-02353-8","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T09:08:41Z","timestamp":1612256921000},"page":"867-878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-2805","authenticated-orcid":false,"given":"Georgina L.","family":"Aitolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluyomi S.","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boluwatife L.","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinyomade O.","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"2353_CR1","first-page":"4","volume-title":"Department of Reproductive Health and Research. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization","year":"2012","unstructured":"World Health Organization (2012) Department of Reproductive Health and Research. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. WHO, Geneva, p 4"},{"key":"2353_CR2","first-page":"1","volume-title":"Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections\u20142008","author":"World Health Organization","year":"2012","unstructured":"World Health Organization (2012) Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections\u20142008. WHO, Geneva, pp 1\u20133"},{"issue":"3","key":"2353_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM (2014) Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27(3):587\u2013613. https:\/\/doi.org\/10.1128\/CMR.00010-14","journal-title":"Clin Microbiol Rev"},{"key":"2353_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","volume":"15","author":"M Unemo","year":"2015","unstructured":"Unemo M (2015) Current and future antimicrobial treatment of gonorrhea\u2013the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 15:364. https:\/\/doi.org\/10.1186\/s12879-015-1029-2","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2353_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrurol.2016.268","volume":"14","author":"M Unemo","year":"2017","unstructured":"Unemo M, Jensen JS (2017) Antimicrobial-resistant sexually transmitted infections: Gonorrhoea and Mycoplasma genitalium. Nat Rev Urol 14(3):139\u2013152","journal-title":"Nat Rev Urol"},{"key":"2353_CR6","unstructured":"World Health Organization (2016) Guidelines for the treatment of Neisseria gonorrhoeae. WHO, Geneva, Switzerland, 2016. http:\/\/apps.who.int\/iris\/bitstream\/10665\/246114\/1\/9789241549691-eng.pdf"},{"issue":"5","key":"2353_CR7","doi-asserted-by":"publisher","first-page":"e00966","DOI":"10.1128\/genomeA.00966-16","volume":"4","author":"A Bharat","year":"2016","unstructured":"Bharat A, Martin I, Demczuk W, Allen V, Haldene D, Hoang L, Mulvey MR (2016) Complete genome sequences of Neisseria gonorrhoeae with coresistance to first-line antimicrobial. Genome Announc 4(5):e00966-e1016. https:\/\/doi.org\/10.1128\/genomeA.00966-16","journal-title":"Genome Announc"},{"issue":"25","key":"2353_CR8","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMc1512757","volume":"374","author":"H Fifer","year":"2016","unstructured":"Fifer H, Natarajan U, Jones L, Alexander S, Hughes G, Golparian D, Unemo M (2016) Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med 374(25):2504\u20132506. https:\/\/doi.org\/10.1056\/NEJMc1512757","journal-title":"N Engl J Med"},{"key":"2353_CR9","first-page":"1","volume":"35","author":"J-AR Dillon","year":"2015","unstructured":"Dillon J-AR, Parti RP, Thakur SD (2015) Antibiotic resistance in Neisseria gonorrhoeae: will infections be untreatable in the future? Culture 35:1\u20138","journal-title":"Culture"},{"issue":"3","key":"2353_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P (2012) High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56(3):1273\u20131280","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2353_CR11","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/OLQ.0000000000000929","volume":"46","author":"AD Cristillo","year":"2019","unstructured":"Cristillo AD, Bristow CC, Torrone E, Dillon JA, Kirkcaldy RD, Dong H, Grad YH, Nicholas RA, Rice PA, Lawrence K, Oldach D, Shafer WM, Zhou P, Wi TE, Morris SR, Klausner JD (2019) Antimicrobial resistance in Neisseria gonorrhoeae: proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting. Sex Transm Dis 46(3):e18\u2013e25. https:\/\/doi.org\/10.1097\/OLQ.0000000000000929","journal-title":"Sex Transm Dis"},{"key":"2353_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01461-19","author":"EN Kersh","year":"2020","unstructured":"Kersh EN, Pham CD, Papp JR, Myers R, Steece R, Kubin G, Weinstock H (2020) Expanding U.S. laboratory capacity for Neisseria gonorrhoeae antimicrobial susceptibility testing and whole-genome sequencing through the CDC\u2019s antibiotic resistance laboratory network. J Clin Microb. https:\/\/doi.org\/10.1128\/JCM.01461-19","journal-title":"J Clin Microb"},{"issue":"4","key":"2353_CR13","doi-asserted-by":"publisher","first-page":"e000359","DOI":"10.1099\/mgen.0.000359","volume":"6","author":"K Alfsnes","year":"2020","unstructured":"Alfsnes K, Eldholm V, Olsen AO, Brynildsrud OB, Bohlin J, Steinbakk M, Caugant DA (2020) Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016\u20132017. Microb Genomics 6(4):e000359. https:\/\/doi.org\/10.1099\/mgen.0.000359","journal-title":"Microb Genomics"},{"key":"2353_CR14","unstructured":"Centre for Disease Prevention and Control (CDC) (2014) Sexually transmitted disease surveillance, national profile. https:\/\/www.cdc.gov\/std\/stats14\/gonorrhea.htm. Accessed 1 June 2017"},{"issue":"3","key":"2353_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1473-3099(13)70693-5","volume":"14","author":"Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Hanage WP, Bentley S, Lipsitch M","year":"2014","unstructured":"Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Hanage WP, Bentley S, Lipsitch M (2014) Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis 14(3):220\u2013226","journal-title":"Lancet Infect Dis"},{"key":"2353_CR16","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2016) Gonococcal antimicrobial susceptibility surveillance in Europe 2014. Stockholm, Sweden. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/gonococcal-antimicrobialsusceptibility-surveillance-Europe-2014.pdf. Accessed 2 June 2017"},{"key":"2353_CR17","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2017) Breakpoint tables for interpretation of MICs and zone diameters. Version 7.0. http:\/\/www.eucast.org\/clinicalbreakpoints\/. Accessed 2 June 2017"},{"key":"2353_CR18","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2017) Performance standards for antimicrobial susceptibility testing. Twenty-seventh informational supplement M100-S27. Wayne"},{"key":"2353_CR19","doi-asserted-by":"publisher","first-page":"iv42","DOI":"10.1136\/sextrans-2012-050909","volume":"89","author":"M Unemo","year":"2013","unstructured":"Unemo M, Ison CA, Cole M, Spiteri G, Van de Laar M, Khotenashvili L (2013) Gonorrhea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union. Sex Transm Infect 89:iv42\u2013iv46. https:\/\/doi.org\/10.1136\/sextrans-2012-050909","journal-title":"Sex Transm Infect"},{"issue":"5","key":"2353_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo M, Lahra MM, Cole M, Galarza P, Ndowa F, Martin I, Wi T (2019) World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health 16(5):412\u2013425. https:\/\/doi.org\/10.1071\/SH19023","journal-title":"Sex Health"},{"issue":"1","key":"2353_CR21","first-page":"E","volume":"41","author":"MM Lahra","year":"2017","unstructured":"Lahra MM, Enriquez RP (2017) National Neisseria Network Australian Gonococcal Surveillance. Programme annual report, 2015. Commun Dis Intell Q Rep 41(1):E","journal-title":"Commun Dis Intell Q Rep"},{"issue":"1","key":"2353_CR22","first-page":"95","volume":"36","author":"MM Lahra","year":"2012","unstructured":"Lahra MM (2012) WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010. Commun Dis Intell Q Rep 36(1):95\u2013100","journal-title":"Commun Dis Intell Q Rep"},{"issue":"4","key":"2353_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3201\/eid2404.171873","volume":"24","author":"MM Lahra","year":"2018","unstructured":"Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI et al (2018) Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis 24(4):735","journal-title":"Emerg Infect Dis"},{"key":"2353_CR24","unstructured":"World Health Organization (2012) Baseline report on global sexually transmitted infection surveillance. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241505895\/en\/. Accessed 2 June 2017"},{"issue":"suppl 4","key":"2353_CR25","doi-asserted-by":"publisher","first-page":"iv11","DOI":"10.1136\/sextrans-2012-050907","volume":"89","author":"FJ Ndowa","year":"2013","unstructured":"Ndowa FJ, Francis JM, Machiha A, Faye-Kette H, Fonkoua MC (2013) Gonococcal antimicrobial resistance: perspectives from the African region. Sex Transm Infect 89(suppl 4):iv11\u2013iv15","journal-title":"Sex Transm Infect"},{"key":"2353_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00906-20","author":"LD Maduna","year":"2020","unstructured":"Maduna LD, Kock MM, van der Veer BM, Radebe O, McIntyre J, van Alphen LB, Peters RP (2020) Antimicrobial resistance of Neisseria gonorrhoeae isolates from high risk men in Johannesburg, South Africa. Antimicrobial Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00906-20","journal-title":"Antimicrobial Agents Chemother"},{"key":"2353_CR27","unstructured":"World Health Organization (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO, Geneva. Available online at: https:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. [verified 18 May 2019]"},{"issue":"7987","key":"2353_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(76)92467-3","volume":"2","author":"WA Ashford","year":"1976","unstructured":"Ashford WA, Golash RG, Henning VG (1976) Penicillinase producing Neisseria gonorrhoeae. Lancet 2(7987):657\u2013658","journal-title":"Lancet"},{"issue":"7987","key":"2353_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0140-6736(76)92466-1","volume":"2","author":"I Phillips","year":"1976","unstructured":"Phillips I (1976) Beta-lactamase producing penicillin-resistant gonococcus. Lancet 2(7987):656\u2013657","journal-title":"Lancet"},{"key":"2353_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/AAC.30.5.664","volume":"30","author":"SA Morse","year":"1986","unstructured":"Morse SA, Johnson SR, Biddle JW, Roberts MC (1986) High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 30:664\u2013670. https:\/\/doi.org\/10.1128\/AAC.30.5.664","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl T1","key":"2353_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/48.suppl_2.1","volume":"48","author":"S Douthwaite","year":"2001","unstructured":"Douthwaite S, Champney WS (2001) Structures of ketolides and mac rolides determine their mode of interaction with the ribosomal target site. J Antimicrob Chemother 48(Suppl T1):1\u20138. https:\/\/doi.org\/10.1093\/jac\/48.suppl_2.1","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2353_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/sti.2010.042648","volume":"86","author":"DA Lewis","year":"2010","unstructured":"Lewis DA (2010) The gonococcus fights back: is this time a knock out? Sex Transm Infect 86(6):415\u2013421. https:\/\/doi.org\/10.1136\/sti.2010.042648","journal-title":"Sex Transm Infect"},{"key":"2353_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","volume":"1","author":"RI Aminov","year":"2010","unstructured":"Aminov RI (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 1:134. https:\/\/doi.org\/10.3389\/fmicb.2010.00134","journal-title":"Front Microbiol"},{"key":"2353_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/medhum-2011-010024","volume":"38","author":"D Davenport","year":"2012","unstructured":"Davenport D (2012) The war against bacteria: how were sulphonamide drugs used by Britain during World War II? Med Hum 38:55\u201358. https:\/\/doi.org\/10.1136\/medhum-2011-010024","journal-title":"Med Hum"},{"key":"2353_CR35","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","volume":"1230","author":"M Unemo","year":"2011","unstructured":"Unemo M, Shafer WM (2011) Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci 1230:E19\u2013E28. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06215.x","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 4","key":"2353_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/sextrans-2012-050905","volume":"89","author":"J-AR Dillon","year":"2013","unstructured":"Dillon J-AR, Trecker MA, Thakur SD (2013) Gonococcal Antimicrobial Surveillance Program Network in Latin America and the Caribbean 1990\u20132011. 2013. Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: challenges and opportunities. Sex Transm Infect 89(Suppl 4):436\u2013441. https:\/\/doi.org\/10.1136\/sextrans-2012-050905","journal-title":"Sex Transm Infect"},{"key":"2353_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12879-015-1148-9","volume":"15","author":"H Zheng","year":"2015","unstructured":"Zheng H, Wu X, Huang J, Qin X, Xue Y, Zeng W, Lan Y, Ou J, Tang S, Fang M (2015) The prevalence and epidemiology of plasmid-mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates in Guangzhou, China, 2002\u20132012. BMC Infect Dis 15:412. https:\/\/doi.org\/10.1186\/s12879-015-1148-9","journal-title":"BMC Infect Dis"},{"issue":"6451","key":"2353_CR38","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/bmj.289.6451.1032","volume":"289","author":"CS Easmon","year":"1984","unstructured":"Easmon CS, Forster GE, Walker GD, Ison CA, Harris JR (1984) Spectinomycin as initial treatment for gonorrhea. Munday PEBr Med J (Clin Res Ed) 289(6451):1032\u20131034","journal-title":"Munday PEBr Med J (Clin Res Ed)"},{"key":"2353_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00007435-199501000-00007","volume":"22","author":"JS Moran","year":"1995","unstructured":"Moran JS (1995) Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis 22:39\u201347","journal-title":"Sex Transm Dis"},{"issue":"42","key":"2353_CR40","doi-asserted-by":"crossref","first-page":"19995","DOI":"10.2807\/ese.16.42.19995-en","volume":"16","author":"M Cole","year":"2011","unstructured":"Cole M, Unemo M, Hoffmann S, Chisholm SA, Ison CA, Van de Laar MJ (2011) The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 16(42):19995","journal-title":"Euro Surveill"},{"issue":"2","key":"2353_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/AAC.01775-12","volume":"57","author":"M Unemo","year":"2013","unstructured":"Unemo M, Daniel G, Vegard S, Anne OO, Harald M, Gaute S, Stig OH (2013) Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway. Antimicrob Agents Chemother 57(2):1057\u20131061. https:\/\/doi.org\/10.1128\/AAC.01775-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2353_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1056\/NEJM198707303170504","volume":"317","author":"Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, Khan WN, Stein DC","year":"1987","unstructured":"Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, Khan WN, Stein DC (1987) Effect of spectinomycin use on the prevalence of spectinomycin-resistant and penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 317:272\u2013278. https:\/\/doi.org\/10.1056\/NEJM198707303170504","journal-title":"N Engl J Med"},{"key":"2353_CR43","unstructured":"World Health Organization (1993) Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR recommendations and reports: morbidity and mortality weekly report recommendations and reports. 42(Rr-14):1\u2013102"},{"issue":"5","key":"2353_CR44","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1046\/j.1365-2958.2003.03496.x","volume":"48","author":"JE Anderson","year":"2003","unstructured":"Anderson JE, Hobbs MM, Biswas GD, Sparling PF (2003) Opposing selective forces for expression of the gonococcal lactoferrin receptor. Mol Microbiol 48(5):1325\u20131337","journal-title":"Mol Microbiol"},{"key":"2353_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0140-6736(90)90177-7","volume":"335","author":"WR Gransden","year":"1990","unstructured":"Gransden WR, Warren CA, Phillips I, Hodges M, Barlow D (1990) Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet 335:51","journal-title":"Lancet"},{"key":"2353_CR46","doi-asserted-by":"publisher","first-page":"371e80","DOI":"10.1111\/j.1365-2958.1994.tb01297.x","volume":"14","author":"RJ Belland","year":"1994","unstructured":"Belland RJ, Morrison SG, Ison C, Huang WM (1994) Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 14:371e80","journal-title":"Mol Microbiol"},{"issue":"5","key":"2353_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/OLQ.0b013e318248a85f","volume":"39","author":"RS Philippe","year":"2012","unstructured":"Philippe RS, Lagace-Wiens PR, Sarah D, Joshua K, Alexander T, Juma S, Scott M, Eduard J-S, George Z, Nicholas M, Supriya DM (2012) Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya. Sex Transm Dis 39(5):332\u2013334. https:\/\/doi.org\/10.1097\/OLQ.0b013e318248a85f","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2353_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/sti.2010.048777","volume":"87","author":"S Duncan","year":"2011","unstructured":"Duncan S, Thiong\u2019o AN, Macharia M, Mwarumba S, Mvera B, Smith AD, Morpeth S, Graham SM, Sanders EJ (2011) High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal Kenya. Sex Transm Infect 87(3):231","journal-title":"Sex Transm Infect"},{"issue":"46","key":"2353_CR49","first-page":"1041","volume":"51","author":"Centers for Disease Control","year":"2002","unstructured":"Centers for Disease Control (2002) Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001. MMWR 51(46):1041\u20131044","journal-title":"MMWR"},{"key":"2353_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/IDR.S105469","volume":"10","author":"S Sethi","year":"2017","unstructured":"Sethi S, Zaman K, Jain N (2017) Mycoplasma genitalium infections: current treatment options and resistance issues. Infect Drug Resist 10:283\u2013292. https:\/\/doi.org\/10.2147\/IDR.S105469","journal-title":"Infect Drug Resist"},{"key":"2353_CR51","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1128\/AAC.46.9.3020-3025.2002","volume":"46","author":"Ng LK, Martin I, Liu,GG Bryden L","year":"2002","unstructured":"Ng LK, Martin I, Liu,GG Bryden L (2002) Mutation in 23S rRNA associated with macrolide resistance in Neisseiria gonorrhoeae. Antimicrob Agents Chemother 46:3020\u20133025. https:\/\/doi.org\/10.1128\/AAC.46.9.3020-3025.2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2353_CR52","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1128\/AAC.00309-10","volume":"54","author":"SA Chisholm","year":"2010","unstructured":"Chisholm SA, Dave J, Ison CA (2010) High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother 54(9):3812\u20133816. https:\/\/doi.org\/10.1128\/AAC.00309-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2353_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s101560170034","volume":"7","author":"S Akasaka","year":"2001","unstructured":"Akasaka S, Muratani T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T (2001) Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. J Infect Chemother 7(1):49\u201350. https:\/\/doi.org\/10.1007\/s101560170034","journal-title":"J Infect Chemother"},{"issue":"1","key":"2353_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","volume":"9","author":"T Deguchi","year":"2003","unstructured":"Deguchi T, Yasuda M, Yokoi S, Ishida K, Ito M, Ishihara S, Minamidate K, Harada Y, Tei K, Kojima K, Tamaki M, Maeda S (2003) Treatment of uncomplicated gonococcal urethritis by double dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother 9(1):35\u201339","journal-title":"J Infect Chemother"},{"key":"2353_CR55","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","volume":"48","author":"M Ito","year":"2004","unstructured":"Ito M, Yasuda M, Yokoi S, Satoshi I, Shin-ichi M, Takashi D (2004) Remarkable increase in central Japan in 2001\u20132002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 48:3185\u20133187","journal-title":"Antimicrob Agents Chemother"},{"key":"2353_CR56","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12879-015-1110-x","volume":"15","author":"K Shimuta","year":"2015","unstructured":"Shimuta K, Watanabe Y, Nakayama S-I, Morita-Ishihara T, Kuroki T, Unemo M, Ohnishi M (2015) Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan. BMC Infect Dis 15:378","journal-title":"BMC Infect Dis"},{"issue":"8","key":"2353_CR57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","volume":"13","author":"S Yokoi","year":"2007","unstructured":"Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, Tamaki M, Maeda S (2007) Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 13(8):1275\u20131277","journal-title":"Emerg Infect Dis"},{"issue":"suppl 1","key":"2353_CR58","first-page":"52","volume":"22","author":"Japanese Society of Sexually Transmitted Infection","year":"2011","unstructured":"Japanese Society of Sexually Transmitted Infection (2011) Gonococcal infection. Sexually transmitted infections, diagnosis and treatment guidelines 2011. Jpn J Sex Transm Dis 22(suppl 1):52\u201359","journal-title":"Jpn J Sex Transm Dis"},{"issue":"7","key":"2353_CR59","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55(7):3538\u20133545","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2353_CR60","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J C\u00e1mara","year":"2012","unstructured":"C\u00e1mara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C (2012) Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 67(8):1858\u20131860. https:\/\/doi.org\/10.1093\/jac\/dks162","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"2353_CR61","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1128\/AAC.01295-13","volume":"57","author":"K Shimuta","year":"2013","unstructured":"Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M (2013) Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother 57(11):5225\u20135232. https:\/\/doi.org\/10.1128\/AAC.01295-13","journal-title":"Antimicrob Agents Chemother"},{"key":"2353_CR62","unstructured":"Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmittedinfections\/canadian-guidelines\/sexually-transmitted-infections\/canadian-guidelines-sexually-transmittedinfections-34.html. Accessed 22 Apr 2018"},{"issue":"5","key":"2353_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/sextrans-2012-050674","volume":"88","author":"F Ndowa","year":"2012","unstructured":"Ndowa F, Lusti-Narasimhan M, Unemo M (2012) The serious threat of multidrug-resistant and untreatable gonorrhea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 88(5):317\u2013318. https:\/\/doi.org\/10.1136\/sextrans-2012-050674","journal-title":"Sex Transm Infect"},{"key":"2353_CR64","unstructured":"Public Health England (2018) UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad; Health Protection Report; Public Health England, London, UK, volume 12"},{"key":"2353_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftx041","author":"AJ Abraham","year":"2020","unstructured":"Abraham AJ, Trees DL (2020) Genomic sequencing of Neisseria gonorrhoeae to respond to the urgent threat of antimicrobial-resistant gonorrhea. Pathog Dis. https:\/\/doi.org\/10.1093\/femspd\/ftx041","journal-title":"Pathog Dis"},{"key":"2353_CR66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12864-019-5542-3","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Dillon JR, Demczuk W, Kusalik A (2019) Gen2Epi: an automated whole-genome sequencing pipeline for linking full genomes to antimicrobial susceptibility and molecular epidemiological data in Neisseria gonorrhoeae. BMC Genomics 20:165. https:\/\/doi.org\/10.1186\/s12864-019-5542-3","journal-title":"BMC Genomics"},{"key":"2353_CR67","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/jac\/dkw288","volume":"71","author":"M Unemo","year":"2016","unstructured":"Unemo M, Golparian D, S\u00e1nchez-Buso L, Grad Y, Jacobsson S, Ohnishi M (2016) The novel 2016 WHO Neisseria gonorrhoeae reference strains for globalquality assurance of laboratory investigations: phenotypic, genetic andreference genome characterization. J Antimicrob Chemother 71:3096\u20133108","journal-title":"J Antimicrob Chemother"},{"key":"2353_CR68","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1473-3099(18)30225-1","volume":"18","author":"RS Harris","year":"2018","unstructured":"Harris RS, Cole MJ, Spiteri G, S\u00e1nchez-Bus\u00f3 L, Golparian D, Jacobsson S, Goater R, Abudahab K, Yeats CA, Bercot B, Borrego MJ, Crowley B, Stefanelli P, Tripodo F, Abad R, Aanensen DM, Unemo M (2018) Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey. Lancet Infect Dis 18:758\u2013768. https:\/\/doi.org\/10.1016\/S1473-3099(18)30225-1","journal-title":"Lancet Infect Dis"},{"key":"2353_CR69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455\u2013477","journal-title":"J Comput Biol"},{"key":"2353_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/sextrans-2017-053287","volume":"94","author":"JC Kwong","year":"2018","unstructured":"Kwong JC, Chow EPF, Stevens K, Stinear TP, Seemann T, Fairley CK, Chen MY, Howden BP (2018) Whole-genome sequencing reveals transmission of gonococcal antibiotic resistance among men who have sex with men: an observational study. Sex Transm Infect 94:151\u2013157. https:\/\/doi.org\/10.1136\/sextrans-2017-053287","journal-title":"Sex Transm Infect"},{"issue":"1","key":"2353_CR71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/nyas.13871","volume":"1435","author":"TD Mortimera","year":"2020","unstructured":"Mortimera TD, Grada YH (2020) Applications of genomics to slow the spread of MDR Neisseria gonorrhoeae. Ann N Y Acad Sci 1435(1):93\u2013109. https:\/\/doi.org\/10.1111\/nyas.13871","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2353_CR72","doi-asserted-by":"publisher","first-page":"e01052","DOI":"10.1128\/genomeA.01052-15","volume":"3","author":"AJ Abrams","year":"2015","unstructured":"Abrams AJ, Trees DL, Nicholas RA (2015) Complete genome sequences of three Neisseria gonorrhoeae laboratory reference strains, determined using PacBio singlemolecule real-time technology. Genome Announc 3(5):e01052-e1115. https:\/\/doi.org\/10.1128\/genomeA.01052-15","journal-title":"Genome Announc"},{"key":"2353_CR73","doi-asserted-by":"publisher","first-page":"e00562","DOI":"10.1128\/mSphere.00562-19","volume":"4","author":"EA Ozer","year":"2019","unstructured":"Ozer EA, Prister LL, Yin S, Ward BH, Ivanov S, Seifert HS (2019) PacBio amplicon sequencing method to measure pilin antigenic variation frequencies of Neisseria gonorrhoeae. mSphere 4:e00562-19. https:\/\/doi.org\/10.1128\/mSphere.00562-19","journal-title":"mSphere"},{"issue":"8","key":"2353_CR74","doi-asserted-by":"publisher","first-page":"e000083","DOI":"10.1099\/mgen.0.000083","volume":"2","author":"AJ Page","year":"2016","unstructured":"Page AJ, De Silva N, Hunt M, Quail MA, Parkhill J, Harris SR (2016) Robust high-throughput prokaryote de novo assembly and improvement pipeline for Illumina data. Microb Genomics 2(8):e000083","journal-title":"Microb Genomics"},{"key":"2353_CR75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.12688\/f1000research.11354.1","volume":"6","author":"Jain M, Tyson JR, Loose M, Ip CL, Eccles DA, O'GradyJ, Malla S, Leggett RM, Wallerman O, Jansen HJ, Zalunin V","year":"2017","unstructured":"Jain M, Tyson JR, Loose M, Ip CL, Eccles DA, O\u2019GradyJ, Malla S, Leggett RM, Wallerman O, Jansen HJ, Zalunin V (2017) MinION Analysis and Reference Consortium: phase 2 data release and analysis of R9.0 chemistry. F1000Research 6:760","journal-title":"F1000Research"},{"issue":"11","key":"2353_CR76","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1101\/gr.191395.115","volume":"25","author":"S Goodwin","year":"2015","unstructured":"Goodwin S, Gurtowski J, Ethe-Sayers S, Deshpande P, Schatz MC, McCombie WR (2015) Oxford nanopore sequencing, hybrid error correction, and de novo assembly of a eukaryotic genome. Genome Res 25(11):1750\u20131756","journal-title":"Genome Res"},{"key":"2353_CR77","unstructured":"Baxter J (2019) Evaluation of Oxford nanopore\u2019s MinION: use, functionality, and genome assembly, 1\u201323"},{"issue":"7","key":"2353_CR78","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s11427-019-1558-8","volume":"63","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wang F, Zhu C, Xiu L, Li Y, Li L, Liu B, Li Y, Zeng Y, Guo B, Peng J (2020) Determining antimicrobial resistance profiles and identifying novel mutations of Neisseria gonorrhoeae genomes obtained by multiplexed MinION sequencing. Sci China Life Sci 63(7):1063\u20131070","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2353_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-35750-4","volume":"8","author":"D Golparian","year":"2018","unstructured":"Golparian D, Don\u00e0 V, S\u00e1nchez-Bus\u00f3 L, Foerster S, Harris S, Endimiani A, Low N, Unemo M (2018) Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer. Sci Rep 8(1):1\u201312","journal-title":"Sci Rep"},{"issue":"2","key":"2353_CR80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/antibiotics7020049","volume":"7","author":"ID Beatriz Suay-Garc\u00eda","year":"2018","unstructured":"Beatriz Suay-Garc\u00eda ID, Mar\u00eda Teresa TP (2018) Future prospect for Neisseria gonorrhoeae treatment. Antibiotics (Basel) 7(2):49. https:\/\/doi.org\/10.3390\/antibiotics7020049","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"2353_CR81","doi-asserted-by":"publisher","first-page":"e1002366","DOI":"10.1371\/journal.pmed.1002366","volume":"14","author":"E Alirol","year":"2017","unstructured":"Alirol E, Wi TE, Bala M, Bazzo ML, Chen XS, Deal C, Dillon J-AR, Kularatne R, Heim J, Hooft van Huijsduijnen R, Hook EW, Lahra MM, Lewis DA, Ndowa F, Shafer WM, Tayler L, Workowski K, Unemo M, Balasegaram M (2017) Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines. PLoS Med 14(7):e1002366. https:\/\/doi.org\/10.1371\/journal.pmed.1002366","journal-title":"PLoS Med"},{"issue":"5","key":"2353_CR82","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.00036-12","volume":"56","author":"D Golparian","year":"2012","unstructured":"Golparian D, Fernandes P, Ohnishi M, Jensen JS, Unemo M (2012) In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother 56(5):2739\u20132742. https:\/\/doi.org\/10.1128\/AAC.00036-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2353_CR83","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/civ478","volume":"61","author":"EW Hook 3rd","year":"2015","unstructured":"Hook EW 3rd, Golden M, Jamieson BD, Dixon PB, Harbison HS, Lowens S, Fernandes PA (2015) Phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea. Clin Infect Dis 61(7):1043\u20131048. https:\/\/doi.org\/10.1093\/cid\/civ478","journal-title":"Clin Infect Dis"},{"key":"2353_CR84","unstructured":"Oldach D (2017) Results of the SOLITAIRE-U Phase 3 trial: solithromycin vs. ceftriaxone + azithromycin for treatment of uncomplicated urogenital gonorrhea. Chapel Hill: Cempra, Inc. Available online at: https:\/\/starstictg.s-3.net\/sites\/default\/files\/page_files\/12.%20Results%20of%20the%20SOLITAIRE-U%20Phase%203%20Trial_Solithromycin_Oldach_4.13.2017.pptx. [verified 18 May 2019]"},{"issue":"1","key":"2353_CR85","doi-asserted-by":"publisher","first-page":"e01808","DOI":"10.1128\/AAC.01808-18","volume":"63","author":"J O\u2019Donnell","year":"2018","unstructured":"O\u2019Donnell J, Lawrence K, Vishwanathan K, Hosagrahara V, Mueller JP (2018) Single-dose pharmacokinetics, excretion, and metabolism of zoliflodacin, a novel spiropyrimidinetrione antibiotic, in healthy volunteers. Antimicrob Agents Chemother 63(1):e01808-e1818","journal-title":"Antimicrob Agents Chemother"},{"key":"2353_CR86","doi-asserted-by":"publisher","first-page":"11827","DOI":"10.1038\/srep11827","volume":"5","author":"GS Basarab","year":"2015","unstructured":"Basarab GS, Kern GH, McNulty J, Mueller JP, Lawrence K, Vishwanathan K, Alm RA, Barvian K, Doig P, Galullo V, Gardner H, Gowravaram M, Huband M, Kimzey A, Morningstar M, Kutschke A, Lahiri SD, Perros M, Singh R, Schuck VJ, Tommasi R, Walkup G, Newman JV (2015) Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases. Sci Rep 5:11827. https:\/\/doi.org\/10.1038\/srep11827","journal-title":"Sci Rep"},{"issue":"3","key":"2353_CR87","doi-asserted-by":"publisher","first-page":"e02047","DOI":"10.1128\/AAC.02047-16","volume":"61","author":"DJ Farrell","year":"2017","unstructured":"Farrell DJ, Sader HS, Rhomberg PR, Scangarella-Oman NE, Flamm RK (2017) In vitro activity of gepotidacin (GSK2140944) against Neisseria gonorrhoeae. Antimicrob Agents Chemother 61(3):e02047-e2116. https:\/\/doi.org\/10.1128\/AAC.02047-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2353_CR88","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cid\/ciy145","volume":"67","author":"SN Taylor","year":"2018","unstructured":"Taylor SN, Morris DH, Avery AK, Workowski KA, Batteiger BE, Tiffany CA, Perry CR, Raychaudhuri A, Scangarella-Oman NE, Hossain M, Dumont EF (2018) Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: a phase 2, randomized, dose-ranging single-oral dose evaluation. Clin Infect Dis 67(4):504\u2013512. https:\/\/doi.org\/10.1093\/cid\/ciy145","journal-title":"Clin Infect Dis"},{"key":"2353_CR89","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/14712598.2019.1651287","volume":"19","author":"A G\u00f3rski","year":"2019","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, Jo\u0144czyk-Matysiak E, Borysowski J, Letkiewicz S, Weber-D\u0105browska B (2019) The fall and rise of phage therapy in modern medicine. Expert Opin Biol Ther 19:1115\u20131117","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"2353_CR90","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v11030268","volume":"11","author":"BO Kim","year":"2019","unstructured":"Kim BO, Kim ES, Yoo YJ, Bae HW, Chung IY, Cho YH (2019) Phage-derived antibacterials: harnessing the simplicity, plasticity, and diversity of phages. Viruses 11(3):268","journal-title":"Viruses"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-021-02353-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:32:14Z","timestamp":1724412734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-021-02353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2353"],"URL":"https:\/\/doi.org\/10.1007\/s00284-021-02353-8","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}